Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NMTC
#3606
NeuroOne Medical Technologies Corporation Common Stock
0.6
7
-2.90%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
-2.90%
Aylık değişim
-26.37%
6 aylık değişim
-8.22%
Yıllık değişim
-40.71%
Önceki kapanış
0.6
9
Open
0.6
7
Bid
Ask
Low
0.6
7
High
0.6
7
Hacim
7
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
NMTC
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Key stats
Total common shares outstanding
30.81 M
30.84 M
30.86 M
49.82 M
50 M
50.41 M
50.53 M
—
Valuation ratios
Enterprise value
25.73 M
29.07 M
24.36 M
41.03 M
25.87 M
38.23 M
34.74 M
139.87 M
Price to earnings ratio
-1.85
-2.15
-3.18
-3.7
-3.99
-9.87
-3.79
-21.35
Price to sales ratio
5.25
7.67
4.06
4.41
3.47
3.92
3.69
15.49
Price to cash flow ratio
-1.78
-2.41
-3.04
-4.56
-5.43
-12.58
-5.75
-28.32
Price to book ratio
1.11
32.23
2.08
3.05
2.05
5.04
1.49
11.64
Enterprise value to EBITDA ratio
-2.15
-2.52
-2.64
-4.56
-3.21
-5.66
-4.74
-18.18
Profitability ratios
Return on assets %
-0.56
-0.62
0.27
-0.51
-0.14
-0.15
-0.17
-0.97
Return on equity %
-0.92
-4.08
0.61
-2.02
-0.18
-0.23
-0.22
-2.65
Return on invested capital %
-739.75
-683.19
249.54
-413.7
-541.53
-334.79
-242.17
-1 532.19
Gross margin %
34.13
51.81
58.85
55.61
53.94
55.77
54.2
219.52
Operating margin %
-338.34
-1 034.48
52.26
-193.29
-111.23
-50.02
-59.02
-413.57
EBITDA margin %
-330.69
-967.57
-31.32
-187.75
-106.32
-46.87
-56.56
-397.51
Net margin %
-335.14
-1 230.55
54.53
-163.76
-88.49
-59.08
-49.71
-361.04
Liquidity ratios
Quick ratio
1.36
0.9
2.41
1.09
5.8
3.47
5.09
15.45
Current ratio
2.42
2.09
3.64
2.13
7.13
4.44
6.41
20.11
Inventory turnover
—
—
0
0
0
0
0
0.01
Asset turnover
0.16
0.05
0.55
0.25
0.22
0.25
0.3
1.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.09
-0.1
0.01
-0
-0.04
-0.04
-0.06
-0.14
EBIT per share
-0.1
-0.11
-0.04
-0.09
-0.05
-0.03
-0.03
-0.21
EBITDA per share
-0.1
-0.1
-0.03
-0.08
-0.05
-0.03
-0.03
-0.2
Total debt per share
—
—
—
—
—
—
—
—
Cash per share
0.06
0.05
0.04
0.04
0.22
0.16
0.07
0.49
Net current asset value per share
0.15
0.17
0.18
0.12
0.28
0.25
0.16
0.81
Tangible book value per share
0.11
0.03
0.09
0.03
0.22
0.18
0.13
0.56
Working capital per share
0.09
0.09
0.13
0.06
0.24
0.2
0.14
0.63
Book value per share
0.11
0.03
0.1
0.04
0.22
0.18
0.13
0.56
Haberler
Best Momentum Stocks to Buy for January 6th
New Strong Buy Stocks for January 6th
신경외과, 페넘브라 임원 제이슨 밀스를 이사회에 임명
NeuroOne appoints Penumbra executive Jason Mills to board
Neuroone Medical Q1 실적, 수익 예상치를 넘어
Neuroone Medical earnings beat, revenue topped estimates
NeuroOne 4분기 실적 급증, 주가 상승
Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises
NeuroOne, 나스닥 상장 유지 위한 기한 연장 승인
NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance
신경원, 나스닥 상장 유지 위해 180일 추가 유예 받아
NeuroOne receives 180-day extension to regain nasdaq compliance